Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group

French pharma services provider, Clean Biologics, has acquired Canadian CDMO, Biodextris, in a move it says will boost its analytical and process development, and early-phase clinical manufacturing and quality control testing services for clients in the vaccine and biologics industries.